Questions on fecal calprotectin's usefulness as a measure of intestinal inflammation in inflammatory bowel disease (IBD) dominated the viewer chat after the opening session of Advances in Inflammatory ...

Calprotectin is then translocated across the epithelial barrier and enters the bowel lumen becoming absorbed by fecal material. The amount of calprotectin present in feces is proportional to the ...

This prospective study in a large cohort of patients examined the use of calprotectin measurement in feces as a diagnostic test to identify clinically significant gastrointestinal findings in patients ...

Please provide your email address to receive an email when new articles are posted on . The AGA formulated 11 conditional recommendations to inform the use of biomarkers in the management of Crohn’s ...

A study suggests that habitual meat intake may relate to a higher risk of ulcerative colitis flares. Image credit: Kriangkrai Thitimakorn/Getty Images The prevalence of IBD is rising, and current ...

Inflammatory Bowel Disease (IBD), which encompasses conditions like Crohn's disease and ulcerative colitis, occurs when the ...

Please provide your email address to receive an email when new articles are posted on . In a prospective study, researchers enrolled 457 asymptomatic participants (mean age 61.4 years; 75% women) from ...

Regular stool tests already used in NHS care, combined with dietary information, could help identify people with inflammatory bowel disease (IBD) at higher risk of relapse, a major study appearing in ...

Fecal calprotectin is a highly sensitive assay that measures inflammation present in the intestinal tract. Gastroenterologists are increasingly ordering fecal calprotectin to screen and monitor ...

Background: The early bacterial colonization of the intestine post partum may affect gut inflammation and risk for disease. Very low birth weight infants (VLBW, < 1500 g) are at risk for ...

I am still haunted by my initiation to Crohn disease. My late brother Andrew, who succumbed to the illness because of a confluence of complications at 29 years-old, first manifested symptoms as a ...